Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
NVST · against 267 other Healthcare companies of similar size
Ranked #93 of 268 · scores higher than 63% of peers
Bars: peers in each 10-point band of the valuation score38 peers with a valuation score of 60–69, including NVST · Click a bar to see the companies
Mainly thanks to its free cash flow yield and EBITDA yield, which are stronger than most Healthcare peers.
| Metric | NVST | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 263 reported | 2.4% | 2.5% | 48% | 30% | |
| EBITDA yieldHigher is better · 262 reported | 9.1% | 4.8% | 78% | 50% | |
| Free cash flow yieldHigher is better · 142 reported | 6.2% | 0.9% | 86% | 20% | |
| Book yieldHigher is better · 261 reported | 77.3% | 27.1% | 90% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 37.3B HKD (≈$4.8B) | 99 | 90 | |
| 1 | 40.2B MXN (≈$2.2B) | 99 | 71 | |
| 5 | 21.1B HKD (≈$2.7B) | 98 | 67 | |
| 93 | 5.1B USD | 66 | 54 | |
| 93 | 217.6B INR (≈$2.6B) | 66 | 67 | |
| 93 | 4.4B USD | 66 | 66 | |
| 93 | 3.2B USD | 66 | 65 | |
| 93 | 4.0B USD | 66 | 56 | |
| 100 | 23.0B CNY (≈$3.2B) | 65 | 64 | |
| 100 | 26.9B CNY (≈$3.8B) | 65 | 65 | |
| 100 | 936.1B JPY (≈$6.4B) | 65 | 80 | |
| 100 | 6.6B USD | 65 | 61 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score